SPOTLIGHT -
Popular insulin meets target in real-world study
Novo Nordisk’s DEVOTE study reveals interesting findings.
New universal companion diagnostic paves the way for precision oncology
FDA approves new diagnostic test for non-small cell lung cancer.
New antibiotic approved for acute bacterial skin infections
FDA approved the use of a new fluoroquinolone antibiotic to treat ABSSSI.
FDA to drug maker: Pull opioid pain drug
Potential public health consquences prompts FDA to request removal of opioid pain medication.
FDA approves EpiPen rival
Adamis’ epinephrine injection promises to be a lower-cost alterative to EpiPen.
FDA approves first generic Truvada for HIV
The first generic Truvada for treating and preventing HIV will be available, but when?
FDA gives once-daily HIV therapy go-ahead
FDA approves Isentress at a higher dose for HIV-1 infected patients.
Asthma biologic may reduce oral steroid use
A new trial for AstraZeneca’s benralizumab shows promising results for severe asthma patients.
First generic Strattera for ADHD approved
FDA has approved the first generic versions of Strattera (atomoxetine) for the treatment of attention deficit/hyperactivity disorder.
Investigational drug appears beneficial in preventing migraines
Lilly's galcanezumab proves successful in three phase 3 migraine studies. Here are the findings.
Drugmaker recalls samples of antiplatelet drug
AstraZeneca voluntarily recalls professional samples of its antiplatelet agent. Here's what to do.
Combination pack approved for breast cancer treatment
FDA approves ribociclib plus letrozole to treat a subset of advanced breast cancer patients.
Top 5 specialty drug management issues
The 13th edition EMD Serono Specialty Digest outlines top specialty drug management issues health plans face.
How pharma reps impact physician prescribing
A new study led by The University of California researchers and published in JAMA reveals surprising findings.
Patient navigators can benefit diabetes outcomes
Study seeks to determine whether significant improvement in glycemic control can be achieved when regular coaching is part of the process.
